Effect of Deferiprone versus Deferiprone with Deferasirox in Iron Chelation Therapy of Thalassemia Children
Journal Title: Journal of Medical Science And clinical Research - Year 2018, Vol 6, Issue 9
Abstract
Background: Thalassemia is an autosomal recessive hemoglobin disorder requiring life-long blood transfusion causing iron overload. Combination therapy of oral iron chelators: Deferiprone (DFP) with Deferasirox (DFX) is an efficacious and safe modality to reduce serum ferritin in multi-transfused thalassemic children. This study was carried out to evaluate the effect of Deferiprone versus Deferiprone with Deferasirox in iron chelation therapy of transfusion dependent thalassemia children. Methodology: A cross sectional observational study was done in Pediatric Hematology and Oncology, Dhaka Medical College Hospital and Bangladesh Thalassemia Hospital in Dhaka from January to June 2018. Children with transfusion dependent β-thalassemia major and E-β-thalassemia having serum ferritin level >1000 ng/ml between 3 to 12 years of age were studied. Results: Demographic profile of 60 cases demonstrated that there are no significant differences in age, sex and weight between DFP-monotherapy and DFP-DFX-combination groups. Initial mean serum ferritin level was 3397.48±774.48 ng/ml in DFP-monotherapy group and 3413.70±1114.05ng/ml in DFP-DFX combination group. After treatment mean serum ferritin level at 6th month was 2730.63±839.91 ng/ml in DFP-monotherapy group and 1654.20±934.90 ng/ml in DFP-DFX-combination group which shows rapid reduction of serum ferritin level in DFP-DFX-combination group. Mean dose of drugs was 72.59(±3.76) mg/kg/ day of DFP in monotherapy group and 68.68(±4.84) mg/kg/ day of DFP and 27.98(±2.13) mg/kg/ day of DFX in combination group. 12 (40.0%) patients had arthralgia in DFP-monotherapy group and 5(16.7%) patients had vomiting in DFP-DFX-combination group. No abnormalities seen in liver and renal function tests. Conclusion: Deferiprone alone is capable in significant excretion of iron from the body in transfusion dependent thalassemia major patients. But combination therapy with Deferiprone and Deferasirox is more significantly effective in iron chelation and drug induced related complications.
Authors and Affiliations
Syeda Jarka Jahir
Keywords
Related Articles
- EP ID EP514962
- DOI -
- Views 90
- Downloads 0
Clinicopathological Analysis of Childhood Leukemia - A Study Conducted in a Tertiary Care Centre in South India
Background: Leukemias constitute the most common diagnostic group of childhood cancers worldwide, and in India, accounting for about 31% of childhood cancers. More than 95% of childhood leukemias are acute leukemias. Sym...
Efficacy and Safety of Tenofovir and Entecavir in Patients with Chronic Hepatitis B - Comparative Cohort Study
Background: Hepatitis B virus (HBV) infection is a global problem and >350 million HBV carriers in the world. HBV infection causes chronic hepatitis and can lead to liver cirrhosis and hepatocellular carcinoma (HCC). Aim...
A Comparative Study of Pro Seal Laryngeal Mask Airway, i-gel and Combitube under General Anaesthesia for Elective Surgical Patients Requiring Controlled Ventilation
Aim: The Pro Seal laryngeal mask airway (PLMA), i-gel and Combi Tube (CT) in past evaluated alone or in group comparisons but differing study designs make it difficult to compare the results. The aim of this study was to...
Prevalence of Hyperhomocysteinemia among Pre-Eclampsia Patients of A Tertiary Referral Hospital in South India
Introduction: Pre-eclampsia is a pregnancy-specific multisystem disorder and is a leading cause of maternal and fetal morbidity and mortality. Several studies have provided evidences that indicate the involvement of hype...
Isolated Fracture of the Trapezium: A Case Report
Trapezium fractures are rare injuries which should not be taken casually. We report a case of a 30 year old left hand dominant housewife who sustained a left sided closed transverse trapezium fracture without any carpome...